Your browser doesn't support javascript.
loading
Post-market surveillance of consumer products: Framework for adverse event management.
Kingston, R; Sioris, K; Gualtieri, J; Brutlag, A; Droege, W; Osimitz, T G.
Afiliación
  • Kingston R; SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Division of Professional Education, College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP)
  • Sioris K; SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP), College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA.
  • Gualtieri J; SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, Department of Experimental and Clinical Pharmacology (ECP), College of Pharmacy, 308 Harvard St SE, Minneapolis, MN, 55455, USA.
  • Brutlag A; SafetyCall International, LLC, 3600 American Blvd W #725, Minneapolis, MN, 55431, USA; University of Minnesota, College of Veterinary Medicine, 1365 Gortner Ave, St Paul, MN, 55108, USA.
  • Droege W; Science Strategies, LLC, 1001 East Market St, Suite 202, Charlottesville, VA, 22902, USA.
  • Osimitz TG; Science Strategies, LLC, 1001 East Market St, Suite 202, Charlottesville, VA, 22902, USA. Electronic address: tom@sciencestrategies.com.
Regul Toxicol Pharmacol ; 126: 105028, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34481892
Analysis of spontaneous reports of adverse events is an important source of information that can be used to improve consumer products. Various agencies have adverse event reporting requirements and many companies collect such data directly from consumers. Nonetheless, a universal framework is absent that identifies and evaluates spontaneously reported adverse events, and, most important, assesses the potential association between exposure and adverse events. We are presenting a three-part framework: Phase I - Intake and Documentation of Original Incidents; Phase II - In Depth Review and Follow-up of Phase I Incidents (enhanced, tailored questionnaire); Phase III - Association Assessment. The basis for scoring the strength of association between exposure and adverse events requires assessment of standard factors of association including: temporality; biological, physiological, or pharmacological plausibility; results of de-challenge; results of re-challenge; and consideration of confounding factors. Scores tied to the answers to these questions are totaled for each incident to determine the strength of association between exposure and reported adverse event. We propose that consumer product companies come together to adopt such an association assessment framework to improve adverse event management, obtain maximum value from the data obtained, and use the knowledge derived to improve overall product safety for consumers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Seguridad de Productos para el Consumidor Tipo de estudio: Prognostic_studies / Qualitative_research / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Regul Toxicol Pharmacol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vigilancia de Productos Comercializados / Seguridad de Productos para el Consumidor Tipo de estudio: Prognostic_studies / Qualitative_research / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Regul Toxicol Pharmacol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos